Government Poised to Fight Off-Label Promotions With FCA after Caronia

Drug Industry Daily
Prosecutors appear ready to lean more heavily on the False Claims Act in prosecuting off-label marketing cases, sidestepping a ruling in the U.S. Second Circuit that found off-label promotion was protected free speech and not prosecutable under the 1938 FD&C Act.

To View This Article:


Subscribe To Drug Industry Daily